Thymosin-α1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes

Immunology Letters

Volumn 110, Issue 2, 2007, Pages 110-120

  Yao, Qizhi ^a   Doan, Linh X ^a   Zhang, Rongxin ^a   Bharadwaj, Uddalak ^a   Li, Min ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Ag uptake; Allogeneic T cell proliferation; Cytokines; Dendritic cell activation; Dendritic cell differentiation; Immature dendritic cells; Mature dendritic cells; Signal transduction; Thymosins

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD40 ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN; THYMOSIN ALPHA1; CYTOKINE; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT; THYMOSIN; THYMOSIN BETA(10); THYMOSIN BETA(4); UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MIXED LYMPHOCYTE REACTION; MONOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; TH2 CELL; BLOOD; CYTOLOGY; IMMUNOLOGY; METABOLISM; MIXED LYMPHOCYTE CULTURE;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD14; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; MONOCYTES; T-LYMPHOCYTES; THYMOSIN;

EID: 34249713219     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.04.007     Document Type: Article

References (29)

1. + T-cell lines specific for HIV gp120. J Acquir Immune Defic Syndr 7 (1994) 15-23
2. Shortman K., and Liu Y.J. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2 (2002) 151-161
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Langhoff E., and Steinman R.M. Clonal expansion of human T-lymphocytes initiated by dendritic cells. J Exp Med 169 (1989) 315-320
5. + cytotoxic T-lymphocytes by dendritic cells. J Exp Med 166 (1987) 182-194
6. Bach J.F. Thymic hormones. J Immunopharmacol 1 (1979) 277-310
7. Li C.L., Zhang T., Saibara T., Nemoto Y., Ono M., Akisawa N., et al. Thymosin alpha 1 accelerates restoration of T-cell-mediated neutralizing antibody response in immunocompromised hosts. Int Immunopharmacol 2 (2002) 39-46
8. Lau G.K., Nanji A., Hou J., Fong D.Y., Au W.S., Yuen S.T., et al. Thymosin-alpha 1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase. J Viral Hepat 9 (2002) 280-287
9. Naylor P.H., Friedman-Kien A., Hersh E., Erdos M., and Goldstein A.L. Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum. Int J Immunopharmacol 8 (1986) 667-676
10. Wolf G.T., Hudson J., Peterson K.A., Poore J.A., and McClatchey K.D. Interleukin 2 receptor expression in patients with head and neck squamous carcinoma. Effects of thymosin alpha 1 in vitro. Arch Otolaryngol Head Neck Surg 115 (1989) 1345-1349
11. Romani L., Bistoni F., Gaziano R., Bozza S., Montagnoli C., Perruccio K., et al. Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 103 (2004) 4232-4239
12. Bistoni F., Baccarini M., Puccetti P., Marconi P., and Garaci E. Enhancement of natural killer cell activity in mice by treatment with a thymic factor. Cancer Immunol Immunother 17 (1984) 51-55
13. Leung N. Treatment of chronic hepatitis B: case selection and duration of therapy. Gastroenterol Hepatol 17 (2002) 409-414
14. Zavaglia C., Severini R., Tinelli C., Franzone J.S., Airoldi A., Tempini S., et al. A randomized, controlled study of thymosin-alpha 1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci 45 (2000) 690-696
15. Chien R.N., Liaw Y.F., Chen T.C., Yeh C.T., and Sheen I.S. Efficacy of thymosin alpha 1 in patients with chronic hepatitis B: a randomized, controlled trial. Hepatology 27 (1998) 1383-1387
16. Naylor P.H., and Mutchnick M.G. Thymus-derived peptides in the treatment of viral chronic hepatitis. Dig Dis 14 (1996) 362-370
17. Chadwick D., Pido-Lopez J., Pires A., Imami N., Gotch F., Villacian J.S., et al. A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy. Clin Exp Immunol 134 (2003) 477-481
18. Garaci E., Pica F., Rasi G., Palamara A.T., and Favalli C. Combination therapy with BRMs in cancer and infectious diseases. Mech Ageing Dev 96 (1997) 103-116
19. Garaci E., Pica F., Rasi G., and Favalli C. Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application. Int J Immunopharmacol 22 (2000) 1067-1076
20. Christenson L., Aebischer P., and Galletti P.M. Encapsulated thymic epithelial cells as a potential treatment for immunodeficiencies. ASAIO Trans 34 (1988) 681-686
21. Ohmori H., Kamo M., Yamakoshi K., Nitta M.H., Hikida M., and Kanayama N. Restoration of immunocyte functions by thymosin alpha 1 in cyclophosphamide-induced immunodeficient mice. Immunopharmacol Immunotoxicol 23 (2001) 75-82
22. Hadden J.W. Immunodeficiency and cancer: prospects for correction. Int Immunopharmacol 3 (2003) 1061-1071
23. Garaci E., Pica F., Sinibaldi-Vallebona P., Pierimarchi P., Mastino A., Matteucci C., et al. Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer. Int Immunopharmacol 3 (2003) 1145-1150
24. Sodhi A., and Paul S. Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1. Int Immunopharmacol 2 (2002) 47-58
25. Shrivastava P., Singh S.M., and Singh N. Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells. J Biomed Sci 11 (2004) 623-630
26. Hannappel E., and Huff T. The thymosins. Prothymosin alpha, parathymosin, and beta-thymosins: structure and function. Vitam Horm 66 (2003) 257-296
27. Low T.L., Thurman G.B., Chincarini C., McClure J.E., Marshall G.D., Hu S.K., et al. Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. Ann N Y Acad Sci 332 (1979) 33-48
28. Zhang P., Chan J., Dragoi A.M., Gong X., Ivanov S., Li Z.W., et al. Activation of IKK by thymosin alpha 1 requires the TRAF6 signalling pathway. EMBO Rep 6 (2005) 531-537
29. Romani L., Bistoni F., Perruccio K., Montagnoli C., Gaziano R., Bozza S., et al. Thymosin α1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance. Blood 108 (2006) 2265-2274